The drug being tested in this study is called vedolizumab. Vedolizumab is being tested to treat people who have Crohn's Disease. This study will look at the endoscopic remission and mucosal healing of gastrointestinal tract of people who take vedolizumab as triple combination therapy with adalimumab and methotrexate.